155 related articles for article (PubMed ID: 8165385)
21. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.
Winkelman JW; Bogan RK; Schmidt MH; Hudson JD; DeRossett SE; Hill-Zabala CE
Mov Disord; 2011 Sep; 26(11):2065-72. PubMed ID: 21611981
[TBL] [Abstract][Full Text] [Related]
22. Leg movements during wakefulness in restless legs syndrome: time structure and relationships with periodic leg movements during sleep.
Ferri R; Manconi M; Plazzi G; Bruni O; Cosentino FI; Ferini-Strambi L; Zucconi M
Sleep Med; 2012 May; 13(5):529-35. PubMed ID: 22341907
[TBL] [Abstract][Full Text] [Related]
23. Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid.
Eisensehr I; Ehrenberg BL; Rogge Solti S; Noachtar S
J Neurol; 2004 May; 251(5):579-83. PubMed ID: 15164191
[TBL] [Abstract][Full Text] [Related]
24. Dissociation of periodic leg movements from arousals in restless legs syndrome.
Manconi M; Ferri R; Zucconi M; Bassetti CL; Fulda S; Aricò D; Ferini-Strambi L
Ann Neurol; 2012 Jun; 71(6):834-44. PubMed ID: 22718547
[TBL] [Abstract][Full Text] [Related]
25. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
26. Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome.
Saletu M; Anderer P; Högl B; Saletu-Zyhlarz G; Kunz A; Poewe W; Saletu B
J Neural Transm (Vienna); 2003 Jun; 110(6):611-26. PubMed ID: 12768357
[TBL] [Abstract][Full Text] [Related]
27. Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease.
LeWitt PA; Huff FJ; Hauser RA; Chen D; Lissin D; Zomorodi K; Cundy KC
Mov Disord; 2014 Jan; 29(1):75-82. PubMed ID: 24339234
[TBL] [Abstract][Full Text] [Related]
28. Levodopa for idiopathic restless legs syndrome: evidence-based review.
Conti CF; de Oliveira MM; Andriolo RB; Saconato H; Atallah AN; Valbuza JS; Coin de Carvalho LB; do Prado GF
Mov Disord; 2007 Oct; 22(13):1943-51. PubMed ID: 17659645
[TBL] [Abstract][Full Text] [Related]
29. Chronic use of triazolam in patients with periodic leg movements, fragmented sleep and daytime sleepiness.
Bonnet MH; Arand DL
Aging (Milano); 1991 Dec; 3(4):313-24. PubMed ID: 1841603
[TBL] [Abstract][Full Text] [Related]
30. Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials.
Mooney ME; Schmitz JM; Moeller FG; Grabowski J
Drug Alcohol Depend; 2007 May; 88(2-3):214-23. PubMed ID: 17134849
[TBL] [Abstract][Full Text] [Related]
31. The influence of the tricyclic antidepressant amitriptyline on periodic limb movements during sleep.
Goerke M; Rodenbeck A; Cohrs S; Kunz D
Pharmacopsychiatry; 2013 May; 46(3):108-13. PubMed ID: 23293012
[TBL] [Abstract][Full Text] [Related]
32. My doctor prescribed Sinemet for my restless legs and it was a catastrophe. Why did you recommend it in a recent article?
Johns Hopkins Med Lett Health After 50; 1998 Feb; 10(12):8. PubMed ID: 9916583
[No Abstract] [Full Text] [Related]
33. Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa.
Staedt J; Wassmuth F; Ziemann U; Hajak G; Rüther E; Stoppe G
J Neural Transm (Vienna); 1997; 104(4-5):461-8. PubMed ID: 9295178
[TBL] [Abstract][Full Text] [Related]
34. Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial.
Ondo WG; Shinawi L; Moore S
Mov Disord; 2010 Dec; 25(16):2724-7. PubMed ID: 20925074
[TBL] [Abstract][Full Text] [Related]
35. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
Fulda S; Wetter TC
Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
[TBL] [Abstract][Full Text] [Related]
36. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables.
Saletu M; Anderer P; Saletu B; Hauer C; Mandl M; Oberndorfer S; Zoghlami A; Saletu-Zyhlarz G
Neuropsychobiology; 2000; 41(4):190-9. PubMed ID: 10828728
[TBL] [Abstract][Full Text] [Related]
37. Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: An RCT.
Bauer A; Cassel W; Benes H; Kesper K; Rye D; Sica D; Winkelman JW; Bauer L; Grieger F; Joeres L; Moran K; Schollmayer E; Whitesides J; Carney HC; Walters AS; Oertel W; Trenkwalder C;
Neurology; 2016 May; 86(19):1785-93. PubMed ID: 27164714
[TBL] [Abstract][Full Text] [Related]
38. L-dopa in uremic patients with the restless legs syndrome.
Sandyk R; Bernick C; Lee SM; Stern LZ; Iacono RP; Bamford CR
Int J Neurosci; 1987 Aug; 35(3-4):233-5. PubMed ID: 3654080
[TBL] [Abstract][Full Text] [Related]
39. Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease.
Wailke S; Herzog J; Witt K; Deuschl G; Volkmann J
Eur J Neurol; 2011 Apr; 18(4):590-6. PubMed ID: 20849470
[TBL] [Abstract][Full Text] [Related]
40. Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study.
Oertel WH; Benes H; Garcia-Borreguero D; Högl B; Poewe W; Montagna P; Ferini-Strambi L; Sixel-Döring F; Trenkwalder C; Partinen M; Saletu B; Polo O; Fichtner A; Schollmayer E; Kohnen R; Cassel W; Penzel T; Stiasny-Kolster K
Sleep Med; 2010 Oct; 11(9):848-56. PubMed ID: 20813583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
